Express Pharma (Vol.11, No.11) April 1-15, 2016
India's Foremost Pharma & Biotech Magazine
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin clarifies on from 483s issued by US FDA for its Mandideep facility
The company believes that the observations are minor in nature and have been already addressed
Govt’s decision to ban 344 FDCs was taken without consideration: Pharma cos to Delhi HC
The government will advance arguments after the pharma companies make their submissions
Sun Pharma enters Japanese prescription market
Acquires 14 prescription brands
Sun Pharma has acquired 14 established prescription brands from Novartis in Japan. According to…
Jubilant Innovation USA to receive up to $22.6 m over acquisition of drug development firm
The payments are on account of an acquisition by a large pharma company of one of their investee companies having assets in early…
Cadila gets US FDA nod to sell generic anti-viral drug
The drugs will be manufactured in Ahmedabad
Aurobindo Pharma receives US FDA approval for rivastigmine tartrate capsules
The product is expected to be launched in Q1 FY16-17
Zydus acquires gastro therapy ‘Actibile’ from Albert David
Strengthens its presence in the gastroenterology segment
Zydus Healthcare, a wholly-owned subsidiary of Cadila Healthcare has…
Panacea Biotec launches CABAPAN
CABAPAN is a cost effective product for the treatment of metastatic castration resistant prostrate cancer
Biocon’s Insulin Glargine receives regulatory approval in Japan
The product is ready to be launched in Q1 FY17